Drug Shortage Report for OZURDEX

Last updated on 2019-04-27 History
Report ID 80819
Drug Identification Number 02363445
Brand name OZURDEX
Common or Proper name dexamethasone intravitreal implant
Market Status MARKETED
Active Ingredient(s) DEXAMETHASONE
Strength(s) 0.7MG
Dosage form(s) IMPLANT
Route of administration INTRAVITREAL
Packaging size 1 implant
ATC code S01BA
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-04-15
Actual start date
Estimated end date 2019-04-30
Actual end date 2019-04-26
Shortage status Resolved
Updated date 2019-04-27
Company comments Rebuilding in country inventory levels following prior supply disruption. Resupply in late April will be sufficient quantity to meet ongoing customer & patient demand.
Health Canada comments
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-04-27 English Compare
v6 2019-04-26 French Compare
v5 2019-04-26 English Compare
v4 2019-04-16 English Compare
v3 2019-04-08 French Compare
v2 2019-04-08 English Compare
v1 2019-04-08 English Compare